ArticleJournal of neuro-oncology2026

Prognostic impact of blood group O in MGMT-methylated glioblastoma patients receiving radiochemotherapy with temozolomide and lomustine.

Julia Scheuble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.